U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232069) titled 'Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis (PRE-EMPT)' on Nov. 14.
Brief Summary: Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. This clinical trial will test if screening and early treatment of mild heart disease works.
PRE-EMPT will screen individuals at low 10-year risk of heart disease with heart disease risk factors to identify those who already have early cholesterol build up, also called "plaque", in their heart arteries. It consists of two phases:
1. A Screening Study - Participants will be assessed for plaque ...